Solarvest Bioenergy Inc

XTSX:SVS

Solarvest BioEnergy, Inc. is an algae biotechnology company, which engages in the development of algal-based production systems. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2006-08-04. The principal business of the Company is the development of its algae-based production systems to develop and commercialize human health products and clean energy. The firm through has its subsidiary developed an algae-based production platform, which is capable of producing various products from Omega 3 fatty acids to human therapeutic proteins. The firm has developed its plant-based organic Omega 3 fatty acids that are rich in Docosahexaenoic Acid/ Eicosapentaenoic Acid (DHA/EPA). Its solar harvesting technology uses the sun, algae, and water to produce clean fuel with no carbon dioxide (CO2) footprint. The company has also initiated a program for the expression of cannabidiol (CBD) and tetrahydrocannabinol (THC) to be produced in good manufacturing practices (GMP) fermentation facilities. Its subsidiaries include Phycobiologics (Europe) Limited, Eversea America Inc., and Eversea Inc.